Mylan Antitrust Suit Over Mirapex Patent Sent To Del.

Law360, New York (March 26, 2010, 2:56 PM EDT) -- A federal judge in Pennsylvania has transferred to Delaware an antitrust suit brought by Mylan Inc. accusing Boehringer Ingelheim International GmbH of filing baseless litigation over a patent for Parkinson's drug Mirapex, ruling that the case belongs in the venue where the disputed patent suit was filed.

Judge Gary L. Lancaster of the U.S. District Court for the Western District of Pennsylvania on Wednesday granted Boehringer's bid to transfer the suit to the U.S. District Court for the District of Delaware.

The Delaware court should hear...
To view the full article, register now.